| Marta Guen Lynch, PSYCHOLOGIST | |
|
800 Hospital Dr, Columbia, MO 65201 | |
| (573) 814-6631 | |
| (573) 814-6267 |
| Full Name | Marta Guen Lynch |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 800 Hospital Dr, Columbia, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326321381 | NPI | - | NPPES |
| 1134125552 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 2011019096 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marta Guen Lynch, PSYCHOLOGIST 800 Hospital Dr, Columbia, MO 65201-5275 Ph: (573) 814-6631 | Marta Guen Lynch, PSYCHOLOGIST 800 Hospital Dr, Columbia, MO 65201 Ph: (573) 814-6631 |
News Archive
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., a pharmaceutical company strongly committed to the respiratory, primary care and CNS therapeutic areas, presented results from SETTLE Phase III study with safinamide at the 17th International Congress of Parkinson's disease and Movement Disorders, taking place from June 16 to 20, 2013, at the Sydney Convention and Exhibition Centre, Sydney, Australia.
Researchers at the Francis Crick Institute, the UCL Cancer Institute, and the Cancer Research UK Lung Cancer Centre of Excellence have identified genetic changes in tumors which could be used to predict if immunotherapy drugs would be effective in individual patients.
Among patients undergoing transcatheter aortic valve replacement, younger age, male sex, history of diabetes mellitus, and moderate to severe residual aortic regurgitation were significantly associated with an increased risk of infective endocarditis, and patients who developed endocarditis had high rates of in-hospital mortality and 2-year mortality, according to a study appearing in the September 13 issue of JAMA.
When looking for new ways to treat aggressive brain cancers, an international team of scientists turned a new leaf and "discovered" the lowly daffodil. A new research study published in the November 2010 print issue of The FASEB Journal (http://www.fasebj.org) offers hope that a natural compound found in daffodil bulbs, called narciclasine, may be a powerful therapeutic against biologically aggressive forms of human brain cancers.
› Verified 3 days ago
Kristin Dyer, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1818 W Worley St, Columbia, MO 65203 Phone: 573-214-3400 | |
Dr. Randee Shenkel, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2804 Forum Blvd Ste 4, Columbia, MO 65203 Phone: 573-446-5034 Fax: 573-446-5046 | |
Jocelyn N Abanes, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Martha Brownlee-duffeck, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Adrionia Marie Molder, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 119 Parker Hall, Columbia, MO 65211 Phone: 573-882-2665 | |
Dr. Noel Marie Elrod, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 211 S 8th St, Columbia, MO 65211 Phone: 573-882-4677 Fax: 573-882-4583 | |
Ellen A Horwitz, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 402 N Keene St, Ste 101, Columbia, MO 65201 Phone: 573-882-6921 Fax: 573-882-1154 |